Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03666026 · ClinicalTrials.gov registry record · NA
Patient Portal - Flu Reminder Recall
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 164,205
- Enrollment target
NCT03666026 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 164,205 participants.
The verdict
NCT03666026, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 164,205 participants
- Enrollment target
Study Summary
This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and \>65 yrs. (63%). The investigators will assess the effectiveness and cost-effectiveness of 1, 2, 3 MyChart R/R messages as compared to the standard of care control (no messages).
Interventions
- BEHAVIORAL 1 MyChart R/R
- BEHAVIORAL 2 MyChart R/R
- BEHAVIORAL 3 MyChart R/R
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164,205 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2019-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03666026
The ClinicalTrials.gov registry entry for NCT03666026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164,205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 1 MyChart R/R is the first listed.
NCT03666026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03666026 about?
NCT03666026 is a clinical study titled "Patient Portal - Flu Reminder Recall". This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70...
What is the current status of trial NCT03666026?
This trial is currently completed. It is a NA study. The enrollment target is 164,205 participants. The study started on 2018-10-02. Estimated completion is 2019-04-02.
What interventions are being tested in trial NCT03666026?
The interventions under investigation include: 1 MyChart R/R (BEHAVIORAL), 2 MyChart R/R (BEHAVIORAL), 3 MyChart R/R (BEHAVIORAL).
Who is sponsoring clinical trial NCT03666026?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.